More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
While Merck can appeal, Halozyme said it expects the order to hold
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Takeda will pay Innovent US$1.2 billion upfront, including a US$100 million equity investment in Innovent
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Growing patent filings and tier-2 innovators reflect expanding national research base
Angelini Ventures has already invested €125 million in 22 startups
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
Subscribe To Our Newsletter & Stay Updated
